Neuland Laboratories receives EIR from USFDA for Bonthapally facility

30 Aug 2019 Evaluate

Neuland Laboratories has received Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its manufacturing facility located at Bonthapally, Hyderabad. The facility was inspected from June 17, 2019 to June 21, 2019.

Neuland Laboratories manufactures active pharmaceutical ingredients for global pharmaceutical companies and provides end-to-end solutions for the pharmaceutical industry for chemistry-related services.

Neuland Laboratories Share Price

13244.40 -367.40 (-2.70%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×